Austrian funding organisation FFG has launched €1m for COVID-19 projects, one of which is Apeptico's project. Furthermore, Apeptico gets funding under a Horizon 2020 grant of €47.5m for 17 COVID-19 projects. ©FFG

Austrian APEPTICO has got Horizon 2020 money for accelerated development and clinical use of Solnatide for the treatment of COVID-19 patients

© Phoenix Locklear/Pixabay.com

The European Medicines Agency EMA has backed eight medicines for approval at its virtual March 2020 meeting.

© Colin Behrens/Pixavay.com

Scandinavian researchers have created a unified, open-source model providing a genome-wide portrait of human disease metabolism.

© CDC

Paris-based Novacyt SA has signed a global distribution agreement with Bruker Ltd for its COVID-19 diagnostic test.

© Pixabay.com/Gerd Altmann

AC Immune SA has received a milestone payment of CHF10m from Eli Lilly and Company.

Chart comparing symptoms in Covid-19 survivors and non-survivors. © Niels Riedemann/Inflarx NV

Scientists have discussed a link between Covid-19 and sepsis at a virtual symposium at Charité Berlin that might help reduce the burden of end-stage disease.

Triple helix structure of collagen. © PRNewsfoto/Evonik Corporation

Evonik Industries has established a new animal-free and fermentation-based industrial-scale recombinant collagen production platform.

© Two German companies, BioNTech and CureVac AG have announced to start trials on Covid-19 mRNA vaccine this spring. © BioNTech SE

Chinese Fosun Pharma Ltd has made the largest investment in a foreign company for a COVID-19 vaccine development: BioNTech’d mRNA vaccine BNT162.

EU Commissioners Frans Timmermans and Virginijus Sinkevi?ius announcing the new circular economy action plan in Brussels. © EC

Under its Green Deal, the European Commission has presented a circular (bio)economay action plan that prepares the ground for a sustainable bio-economy.

Three-dimensional reconstruction of dendritic cells incubated with an anti-PD-L1 antibody. © M. Mayoux et al., Science Translational Medicine (2020)

Researchers at Swiss pharma giant Roche AG have found a subpopulation of dendritic cells to determine how cancer patients respond to immune checkpoint inhibitors.